Evaluation of the anti-HER2 C6.5 diabody as a PET radiotracer to monitor HER2 status and predict response to trastuzumab treatment
评估抗 HER2 C6.5 双抗体作为 PET 放射性示踪剂监测 HER2 状态和预测曲妥珠单抗治疗反应
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-10-1654
Smitha Reddy, Calvin C Shaller, Mohan Doss, Irina Shchaveleva, James D Marks, Jian Q Yu, Matthew K Robinson
